Cargando…
MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma
BACKGROUND: Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer worldwide. Growing evidence showed that Melanoma-associated antigen-A11 (MAGE-A11) was abnormally expressed in various malignancies, but MAGE-A11 expression and its biological roles in HNSCC had not been rep...
Autores principales: | Jia, Shiheng, Zhang, Minghui, Li, Yanshu, Zhang, Lan, Dai, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051897/ https://www.ncbi.nlm.nih.gov/pubmed/32161495 http://dx.doi.org/10.2147/CMAR.S237867 |
Ejemplares similares
-
Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways
por: Li, Yanshu, et al.
Publicado: (2020) -
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy
por: Laban, Simon, et al.
Publicado: (2017) -
NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma
por: Ueda, Shugo, et al.
Publicado: (2018) -
Expression of MAGE-A12 in Oral Squamous Cell Carcinoma
por: Mollaoglu, Nur, et al.
Publicado: (2008) -
Expression of MAGE‐B Genes in Esophageal Squamous Cell Carcinoma
por: Nagashima, Hideki, et al.
Publicado: (2001)